EUVIMEDScopri EUVIMED
BeobachtungsstudieKohortenstudieOpen access

Respiratory-Responsive Vocal Biomarker for Asthma Exacerbation Monitoring: Prospective Cohort Study

Erik Larsen iD, Xinyu Song iD, Dale Joachim iD, Peter Y Ch'en iD, Samuel M Green iD, Emily Hunt iD, Savneet Kaur iD, Robin Nag iD, Olivia Pisani iD, Sherron Thomas iD, Victoria Adewunmi iD, Carlo Lutz iD and 3 more

Journal of Medical Internet Research · 2025-09-23 · 27 · e68741

DOI: 10.2196/68741 ↗

At a glance

Beobachtungsstudie in Journal of Medical Internet Research, published online on 2025-09-23. Written by Erik Larsen and 14 co-authors. Institution: Sonde Health, Somerville, MA, United States. Major MEDLINE topics: Asthma, Voice. Cited 4 times so far (Crossref); 31 references. The full text is freely available in PubMed Central.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Asthma exacerbations remain a major challenge in asthma management, often due to delayed recognition and limitations of conventional monitoring tools such as peak flow meters and symptom questionnaires. These tools are typically effort dependent or retrospective, making them less suited for continuous, real-time monitoring. A novel, smartphone-based respiratory-responsive vocal biomarker (RRVB) may offer an accessible and noninvasive approach for dynamic assessment of respiratory health. This RRVB has previously demonstrated generalizable performance in cross-sectional cohorts across multiple respiratory conditions, including asthma, chronic obstructive pulmonary disease, and COVID-19, in populations spanning India and the United States. This study extended this work by evaluating the real-world, longitudinal performance of the same RRVB tool for daily asthma exacerbation monitoring via smartphones in home settings.

Objective

This study aimed to evaluate the efficacy of the RRVB as a convenient real-time tool for monitoring asthma exacerbations and respiratory states in a real-world, longitudinal setting.

Methods

In this prospective cohort study, 84 adult patients with asthma were enrolled from an academic medical center and followed for 90 days. Participants submitted daily 6-second voice samples and conducted peak expiratory flow measurements and surveys, including symptom reports and asthma control assessments. RRVB scores were generated in real time on the app. Asthma states (normal function, mild event, and exacerbation) were defined based on both peak expiratory flow and self-reported well-being. Risk ratios were calculated to assess the predictive validity of RRVB scores for identifying exacerbation events. Engagement was measured via frequency of completed sessions, and participant experience was evaluated through exit surveys.

Results

RRVB scores significantly stratified asthma states. The risk of experiencing an exacerbation was 2.15 times higher (95% CI 1.62-2.85; P

Subjects

MeSH terms (MEDLINE)

AsthmaVoiceAdultAgedFemaleHumansMaleMiddle AgedBiomarkersCOVID-19Monitoring, PhysiologicPeak Expiratory Flow RateProspective StudiesSmartphone

Author keywords

asthma managementdigital healthmHealthmobile healthpatient engagementremote monitoringrespiratory exacerbationvocal biomarkers

Substances

Biomarkers

Authors and institutions

  • Sonde Health, Somerville, MA, United States.
  • Albert Einstein College of Medicine, Bronx, NY, United States.
  • Montefiore Medical Center, Bronx, NY, United States.
  • Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, United States.

ORCID profiles: Erik Larsen, Xinyu Song, Dale Joachim, Peter Y Ch'en, Samuel M Green, Emily Hunt, Savneet Kaur, Robin Nag, Olivia Pisani, Sherron Thomas, Victoria Adewunmi, Carlo Lutz, Babak Baghizadeh-Toosi, Jonathan M Feldman, Sunit Jariwala

Cite

APA

Larsen, E., Song, X., Joachim, D., Ch'en, P. Y., M Green, S., Hunt, E., Kaur, S., Nag, R., Pisani, O., Thomas, S., Adewunmi, V., Lutz, C., Baghizadeh-Toosi, B., Feldman, J. M., & Jariwala, S. (2025). Respiratory-Responsive Vocal Biomarker for Asthma Exacerbation Monitoring: Prospective Cohort Study. Journal of Medical Internet Research, 27, e68741. https://doi.org/10.2196/68741

Vancouver

Larsen E, Song X, Joachim D, Ch'en PY, M Green S, Hunt E, et al. Respiratory-Responsive Vocal Biomarker for Asthma Exacerbation Monitoring: Prospective Cohort Study. Journal of Medical Internet Research. 2025;27:e68741. doi:10.2196/68741

BibTeX
@article{Larsen2025,
  author = {Larsen, Erik and Song, Xinyu and Joachim, Dale and Ch'en, Peter Y and M Green, Samuel and Hunt, Emily and Kaur, Savneet and Nag, Robin and Pisani, Olivia and Thomas, Sherron and Adewunmi, Victoria and Lutz, Carlo and Baghizadeh-Toosi, Babak and Feldman, Jonathan M and Jariwala, Sunit},
  title = {Respiratory-Responsive Vocal Biomarker for Asthma Exacerbation Monitoring: Prospective Cohort Study},
  journal = {Journal of Medical Internet Research},
  year = {2025},
  volume = {27},
  pages = {e68741},
  doi = {10.2196/68741}
}
Start for free →